| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 2497 |
| 1 | ADALIMUMAB | 1618 |
| 2 | ETANERCEPT | 1439 |
| 3 | PREDNISONE | 1368 |
| 4 | METHOTREXATE SODIUM | 1306 |
| 5 | INSULIN GLARGINE | 1215 |
| 6 | METHOTREXATE | 1146 |
| 7 | ASPIRIN | 1135 |
| 8 | ERGOCALCIFEROL | 1082 |
| 9 | ASPIRIN 325 MG | 1079 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERGOCALCIFEROL | 1082 | 0.0364 |
| 1 | TROPICAMIDE | 51 | 0.0312 |
| 2 | INFLIXIMAB-DYYB | 107 | 0.0311 |
| 3 | BELANTAMAB MAFODOTIN | 92 | 0.0296 |
| 4 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 70 | 0.0276 |
| 5 | CARBOXYMETHYLCELLULOSE SODIUM | 154 | 0.0271 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | 56 | 0.0221 |
| 7 | LIFITEGRAST | 338 | 0.0205 |
| 8 | ZIPRASIDONE | 64 | 0.0178 |
| 9 | TOBRAMYCIN AND DEXAMETHASONE | 57 | 0.0171 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3043 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2834 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2497 |
| 3 | Insulin Analog [EPC] | 2011 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 1968 |
| 5 | Benzodiazepine [EPC] | 1324 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 1173 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1144 |
| 8 | Vitamin C [EPC] | 1104 |
| 9 | Provitamin D2 Compound [EPC] | 1082 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 127 | 0.1846 |
| 1 | Disclosing Agent [EPC] | 1 | 0.0476 |
| 2 | Provitamin D2 Compound [EPC] | 1082 | 0.0364 |
| 3 | Adrenocorticotropic Hormone [EPC] | 19 | 0.0212 |
| 4 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 338 | 0.0205 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 39 | 0.0188 |
| 6 | Semifluorinated Alkane [EPC] | 38 | 0.0163 |
| 7 | Antileishmanial [EPC] | 6 | 0.0155 |
| 8 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 76 | 0.0128 |
| 9 | Prostaglandin Analog [EPC] | 987 | 0.0106 |